ABio 的科學根基源自幹細胞研究 —— 當人體組織受損時，間質幹細胞會釋放外泌體，傳遞「細胞再生」與「膠原合成」的修復訊號。ABio 以此為起點、超過 20 年專研，將這門科學轉化為安全、穩定且可量產的植物外泌體技術。
ABio's science is rooted in stem-cell research — when human tissue is injured, mesenchymal stem cells release exosomes that signal cell regeneration and collagen synthesis. Building on this, ABio spent 20+ years turning the science into safe, stable, scalable plant-exosome technology.
ABio Materials 為韓國先進生物材料公司，長年為國內外領導品牌製造與供應生物材料及原料。ABio 承接外泌體專家 Prostemics 的外泌體事業，全力投入慢老化（Slow-aging）研究，並培育多達 29 種植物外泌體，應用於各種肌膚問題。
ABio Materials is a Korean advanced-biomaterials company supplying biomaterials to leading brands worldwide. It acquired the exosome business of Prostemics and devoted itself to slow-aging research — cultivating up to 29 plant-based exosomes for a wide range of skin concerns.
ABio 的外泌體科技並非從零開始，而是承襲自韓國再生醫學的先驅——Prostemics（株式會社 Bio Prostemics）。Prostemics 成立於 2005 年、總部位於首爾，是韓國掛牌上市的尖端生技企業，長年深耕人體脂肪間質幹細胞（ADSC）培養液與外泌體研究，是全球幹細胞再生醫學與醫美原料領域的領先開拓者。
ABio's exosome technology didn't start from scratch — it descends from a pioneer of Korean regenerative medicine, Prostemics (Bio Prostemics Co., Ltd.). Founded in 2005 and headquartered in Seoul, Prostemics is a publicly listed advanced-biotech company with deep expertise in human adipose-derived stem cell (ADSC) conditioned media and exosomes — a leading pioneer in global stem-cell regenerative medicine and aesthetic biomaterials.
韓國掛牌上市的尖端生物科技企業，深耕再生醫學近 20 年。
A publicly listed Korean biotech, advancing regenerative medicine for nearly two decades.
人體脂肪間質幹細胞培養液技術先驅，釋放高活性生長因子。
Pioneer of adipose stem-cell conditioned media, rich in bioactive growth factors.
全球首款以人體幹細胞外泌體為核心的抗衰老原料，獲多國診所採用。
A first-of-its-kind stem-cell exosome anti-aging active, adopted by clinics worldwide.
修復功效經多篇國際醫學期刊實證，並取得多項跨國專利。
Its paracrine repair mechanism is validated in journals and protected by cross-border patents.
其代表性成果 AAPE® 被多國皮膚科與醫美診所廣泛採用，臨床證實能活化毛囊、促進毛髮增生，並顯著提升受損肌膚的細胞再生與組織修復。ABio 正是承接這套世界級的幹細胞與外泌體科技，進一步發展為安全、穩定且可量產的植物外泌體 —— 這正是奧泌與肌泌背後深厚的科學底蘊。
Its flagship active AAPE® is widely used by dermatology and aesthetic clinics across many countries, clinically shown to activate hair follicles, stimulate hair growth and markedly enhance cell regeneration and tissue repair in damaged skin. ABio carries this world-class stem-cell and exosome science forward — evolving it into safe, stable, scalable plant exosomes, the scientific foundation behind both the Cellexosome and Lumidor series.
ABio 於製藥級設施中生產，落實嚴謹的品質與環境管理，確保每一批產品的安全與一致性。
ABio manufactures in pharmaceutical-grade facilities with rigorous quality and environmental controls, ensuring the safety and consistency of every batch.
優良製造規範，確保製程與品質的一致性。
Good Manufacturing Practice for consistent process and quality.
醫療器材品質管理系統國際標準。
International standard for medical-device quality management.
植物外泌體培養與 1B 級（10,000 級）潔淨環境。
Plant-exosome culture in a Class 1B (10,000) clean environment.
以自主技術進行植物外泌體的大規模培養與純化。
Proprietary large-scale cultivation and purification of plant exosomes.
栽培專屬植物品系，源頭把關原料品質。
Cultivating proprietary plant strains to control raw-material quality at source.
持續發表外泌體相關科學研究，累積實證基礎。
Ongoing exosome research published to build an evidence base.
ABio 累積 62 項國際專利技術，涵蓋積雪草與多元植物外泌體、幹細胞應用與奈米穩定化技術；並持續發表於國際皮膚醫學期刊，建立客觀科學實證。
ABio holds 62 international patents spanning Centella and diverse plant exosomes, stem-cell applications and nano-stabilization technology — backed by ongoing publication in international dermatology journals.
積雪草外泌體純化、智慧農場栽培與高活性成分萃取相關專利。
Centella-asiatica exosome purification, Smart-Farm cultivation and high-potency extraction.
涵蓋鳶尾根、無花果、迷迭香、蓮花、蕨類、茶樹、牡丹、番茄、花椰菜、葡萄柚、山茶花、綠茶、燕麥、貓薄荷、菠菜、鬱陵菊、銀杏、南瓜等 18 項植物外泌體專利。
18 patents spanning iris, fig, rosemary, lotus, fern, tea tree, peony, tomato, broccoli, grapefruit, camellia, green tea, oat, catnip, spinach, chrysanthemum, ginkgo and pumpkin.
涵蓋外泌體分離、miRNA 組成物、抗落髮與傷口修復等應用專利。
Exosome isolation, miRNA compositions, anti-hair-loss and wound-repair applications.
脂質奈米顆粒、神經醯胺穩定化等傳遞與保存技術專利。
Lipid nanoparticle and ceramide stabilization technologies for delivery and shelf-life.
植物栽培裝置與活性成分強化栽培法相關專利。
Plant cultivation devices and bioactive-enhancing growing methods.
涵蓋 PDRN 製備、益生菌衍生物等生物材料相關專利。
PDRN preparation, probiotic-derived microvesicles and other biomaterial patents.
源自 ABio 承接的外泌體專家 Prostemics 科研根基，長期發表於國際皮膚醫學期刊，是外泌體科學實證的重要基礎。
Rooted in the research legacy of exosome specialist Prostemics (acquired by ABio), these publications in international dermatology journals form the scientific foundation of the exosome technology.
※ 資料來源：ABio 原廠官網公開之國際期刊與全球專利列表。
※ Source: ABio's official list of international journals and global patents.
美國 FDA 產品登錄、國際專利與相關認證，是原廠品質的客觀實證。
US FDA product listings, international patents and certifications — objective proof of original quality.
※ 滑鼠移入可暫停；證書為原廠提供之部分範例。
※ Hover to pause; a selection of manufacturer-provided certificates.
再生王醫學科技為 ABio Materials 台灣總代理經銷，提供原廠產品與專業療程支援。
Regen Medical is the official Taiwan distributor of ABio Materials, offering original products and professional support.